In the past week, VSTM stock has gone up by 9.12%, with a monthly gain of 21.54% and a quarterly plunge of -8.00%. The volatility ratio for the week is 4.90%, and the volatility levels for the last 30 days are 6.15% for Verastem Inc The simple moving average for the past 20 days is 12.70% for VSTM’s stock, with a -60.06% simple moving average for the past 200 days.
Is It Worth Investing in Verastem Inc (NASDAQ: VSTM) Right Now?
Moreover, the 36-month beta value for VSTM is 0.16. Analysts have varying opinions on the stock, with 3 analysts rating it as a “buy,” 1 as “overweight,” 1 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for VSTM is 36.71M and currently, short sellers hold a 5.61% of that float. On October 01, 2024, VSTM’s average trading volume was 621.92K shares.
VSTM) stock’s latest price update
The stock price of Verastem Inc (NASDAQ: VSTM) has jumped by 11.15 compared to previous close of 2.69. Despite this, the company has seen a gain of 9.12% in its stock price over the last five trading days. businesswire.com reported 2024-09-10 that BOSTON–(BUSINESS WIRE)–Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Wednesday, September 18 at 3:40 pm EDT. A live webcast of the fireside chat can be accessed under “Events & Presentations” in the Investors & Media section of the company’s website at www.verastem.com. A replay of.
Analysts’ Opinion of VSTM
BTIG Research, on the other hand, stated in their research note that they expect to see VSTM reach a price target of $27. The rating they have provided for VSTM stocks is “Buy” according to the report published on November 21st, 2023.
B. Riley Securities gave a rating of “Buy” to VSTM, setting the target price at $21 in the report published on September 27th of the previous year.
VSTM Trading at 14.51% from the 50-Day Moving Average
After a stumble in the market that brought VSTM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.97% of loss for the given period.
Volatility was left at 6.15%, however, over the last 30 days, the volatility rate increased by 4.90%, as shares surge +19.60% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -9.94% lower at present.
During the last 5 trading sessions, VSTM rose by +9.12%, which changed the moving average for the period of 200-days by -57.47% in comparison to the 20-day moving average, which settled at $2.68. In addition, Verastem Inc saw -63.27% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VSTM starting from Calkins Daniel, who sale 65 shares at the price of $2.80 back on Sep 20 ’24. After this action, Calkins Daniel now owns 47,495 shares of Verastem Inc, valued at $182 using the latest closing price.
Calkins Daniel, the Chief Financial Officer of Verastem Inc, sale 28 shares at $2.68 during a trade that took place back on Sep 24 ’24, which means that Calkins Daniel is holding 47,467 shares at $75 based on the most recent closing price.
Stock Fundamentals for VSTM
Current profitability levels for the company are sitting at:
- -9.77 for the present operating margin
- 1.0 for the gross margin
The net margin for Verastem Inc stands at -8.85. The total capital return value is set at -1.31. Equity return is now at value -109.97, with -60.16 for asset returns.
Based on Verastem Inc (VSTM), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at -2.44. The debt to equity ratio resting at 1.05. The interest coverage ratio of the stock is -21.87.
Currently, EBITDA for the company is -92.02 million with net debt to EBITDA at 0.43. When we switch over and look at the enterprise to sales, we see a ratio of 7.79. The receivables turnover for the company is 0.93for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.28.
Conclusion
To wrap up, the performance of Verastem Inc (VSTM) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
